- Graduate School - Harvard University School of Public Health (1999-2001), Epidemiology
- Fellowship - Harvard Medical School/Brigham & Women's Hospital (1996-1997), Congestive Heart Failure/cardiac Transplant
- Fellowship - Duke University School of Medicine (1993-1996), Cardiology
- Chief Resident - UT Southwestern Medical School (1992-1993), Internal Medicine
- Residency - UT Southwestern Medical Center (1990-1992), Internal Medicine
- Internship - UT Southwestern Medical Center (1989-1990), Internal Medicine
- Medical School - Washington University School of Medicine (1985-1989)
- Other Post Graduate Training - Harvard University School of Public Health (1999-2001)
Mark Drazner, M.D.
Clinical Chief of Cardiology; Medical Director of the LVAD and Cardiac Transplantation Program
- James M. Wooten Chair in Cardiology
- Internal Medicine - Cardiology
- Heart Failure & Cardiac Support
Mark Drazner, M.D., is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center. He specializes in treating patients with cardiomyopathy and advanced heart failure, including those who undergo a heart transplant or implantation of a ventricular assist device to help the heart pump blood. He is the Clinical Chief of Cardiology at UT Southwestern and the Medical Director of the Left Ventricular Assist Device (LVAD) and Cardiac Transplant Program. He holds the James M. Wooten Chair in Cardiology.
Dr. Drazner earned his medical degree at Washington University in St. Louis. He completed a residency in internal medicine at UT Southwestern Medical School, where he was Chief Resident. He received advanced training in cardiology through a fellowship at Duke University and then further specialized training in heart failure/cardiac transplantation through a fellowship at Brigham and Women’s Hospital. He also earned a Master of Science in epidemiology at Harvard University School of Public Health.
Dr. Drazner was one of the first physicians in North Texas to be certified by the American Board of Internal Medicine in the new subspecialty of advanced heart failure and transplant cardiology.
He has been at the forefront of research in heart failure and cardiac transplantation and has published numerous academic articles in top medical journals.
Dr. Drazner is a member of several professional organizations, including the American Heart Association, the American College of Cardiology, the Heart Failure Society of America, and the International Society for Heart and Lung Transplantation.
He has been selected as a Best Doctor by D Magazine, a Super Doctor by Texas Monthly, a Best Doctor in America by Best Doctors Inc., and a Top Doctor by Castle Connolly on numerous occasions.
Meet Dr. Drazner
Dallas Heart Failure Specialist
A diagnosis of heart failure might seem ominous, but it is treatable, thanks to the expertise and skills of physicians like Mark Drazner, M.D. A nationally recognized expert in the care of patients with advanced heart disease, Dr. Drazner specializes in treating patients with cardiomyopathy and those needing a heart transplant or implantation of a ventricular assist device.
"If you’re being treated for heart failure and you’re not improving, consider seeing a cardiologist who specializes in patients with advanced heart failure," Dr. Drazner says.
“Cardiac transplantation is the gold-standard therapy for advanced heart disease, but its use is constrained by the availability of donor organs,” Dr. Drazner says. “Chronic drug infusions are sometimes helpful for symptoms, but they don’t prolong life. Fortunately, advances in the development of left ventricular assist devices (LVADs), which are essentially mechanical heart pumps implanted in the body, have opened a new era in treating patients with a failing heart.”
LVADs can serve as a bridge to transplant, keeping patients alive until a donor heart becomes available, or they can prolong survival and improve quality of life for patients who are not transplant candidates.
It’s an area of medical therapy that Dr. Drazner knows well: He’s the Medical Director of the LVAD and Cardiac Transplant Program at UT Southwestern.
“Our program is among the best in the country,” he says, “and it’s a terrific resource for the community.”
- International Society of Heart and Lung Transplantation
- Heart Failure Society of America
- American Heart Association
- American College of Cardiology
- D Magazine Best Doctor 2020
- D Magazine Best Doctor 2010
- Texas Super Doctors 2008
- Best Doctors in America 2003
- AOA 1989
Outcomes after emergency department discharge with a primary diagnosis of heart failure.
Rame, JE, Sheffield, MA, Dries, DL, Gardner, EB, Toto, KH, Yancy CW, Drazner, MH American Heart Journal 2001 142 714-719
Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure.
Drazner MH, Rame JE, Stevenson LW, Dries DL The New England journal of medicine 2001 Aug 345 8 574-81
Comparison of impedance cardiography with invasive hemodynamic measurements in patients with heart failure secondary to ischemic or nonischemic cardiomyopathy.
Drazner, MH, Thompson, B, Rosenberg, PB, Kaiser, PA, Boehrer, JD, Baldwin, BJ, Dries, DL, Yancy, CW. American Journal of Cardiology 2002 89 993-995
Efficacy of angiotensin-converting enzyme inhibtion in reducing progression from asymptomatic left ventricular dysfunction to symptomatic heart failure in black and white patients
Dries, DL, Strong, MH, Cooper, RS, Drazner, MH Journal of American College Cardiology 2002 40 311-317
Development of a depressed left ventricular ejection fraction in patients with left ventricular hypertrophy and a normal ejection fraction.
Rame, JE, Ramilo, M, Spencer, N, Blewett, C, Mehta, SK, Dries, DL, Drazner, MH. Am J Cardiol 2004 93 234-237
Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction: the Cardiovas
Drazner, MH, Rame, JE, Marino, EK, Gottdiener, JS, Kitzman, DW, Gardin, JM, Manolio, T, Dries, DL, Siscovick DS. J Am Coll Cardiol 2004 43 2207-1215
Health insurance and cardiac transplantation: a call for reform.
King, LP, Siminoff, LA, Meyer, DM, Yancy, CW, Ring, WS, Mayo, TW, Drazner, MH. J Am Coll Cardiol 2005 45 1388-1391
From hypertrophy to failure: how certain are we?
Drazner, MH Circulation 2005 112 936-938
Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: the Dallas Heart Study.
Drazner, MH, Dries, DL, Peshock, RM, Cooper, RS, Klassen, C, Kazi, F, Willett, D, Victor, RG. Hypertension 2005 46 1-6
Induction therapy with Basiliximab allows delayed initiation of Cyclosporine and preserves renal function following cardiac
Rosenberg, PB, Vriesendorp, AE, Drazner, MH, Dries, DL, Kaiser, PA, Hynan, LH, DiMaio, JM, Meyer, D, Ring, WS, Yancy, CW. J Heart Lung Transplant 2005 24 1327-1331
Concentric left ventricular hypertrophy as assessed by cardiac magnetic resonance imaging and risk of death in cardiac transplant recipients.
Patel PC, Reimold SC, Araj FG, Ayers CR, Kaiser PA, Peshock RM, Yancy CW, Ring WS, Gupta S, Mishkin JD, Mammen PP, Markham DW, Drazner MH The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2010 Dec 29 12 1369-79
The relationship of right- and left-sided filling pressures in patients with heart failure and a preserved ejection fraction.
Drazner MH, Prasad A, Ayers C, Markham DW, Hastings J, Bhella PS, Shibata S, Levine BD Circulation. Heart failure 2010 Mar 3 2 202-6
A 4-tiered classification of left ventricular hypertrophy based on left ventricular geometry: the Dallas heart study.
Khouri MG, Peshock RM, Ayers CR, de Lemos JA, Drazner MH Circulation. Cardiovascular imaging 2010 Mar 3 2 164-71
The progression of hypertensive heart disease.
Drazner MH Circulation 2011 Jan 123 3 327-34
Progression from Normal to Reduced Left Ventricular Ejection Fraction in Patients With Concentric Left Ventricular Hypertrophy After Long-Term Follow-Up.
Krishnamoorthy A, Brown T, Ayers CR, Gupta S, Rame JE, Patel PC, Markham DW, Drazner MH The American journal of cardiology 2011 Jul 997-1001
Relationship of right- and left-sided filling pressures in patients with advanced heart failure: a 14-year multi-institutional analysis.
Drazner MH, Brown RN, Kaiser PA, Cabuay B, Lewis NP, Semigran MJ, Torre-Amione G, Naftel DC, Kirklin JK The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2012 Jan 31 1 67-72
Utilization of cardiac computed tomography angiography for the diagnosis of left ventricular assist device thrombosis.
Mishkin JD, Enriquez JR, Meyer DM, Bethea BT, Thibodeau JT, Patel PC, Markham DW, Mammen PP, Velez-Martinez M, Drazner MH Circulation. Heart failure 2012 Mar 5 2 e27-9
- Outcomes after emergency department discharge with a primary diagnosis of heart failure.
- Left ventricular Hypertrophy
- Cardiac Transplantation
- Advanced Heart Failure
- Heart Failure & Cardiac Support
- Heart Transplant Medicine
Q&A by Dr. Drazner
Articles by Dr. Drazner
Leaders in Clinical Excellence video: Dr. Mark Drazner
AHA Scientific Session: Dr. Mark Drazner
Mark Drazner, M.D., Clinical Chief of Cardiology at UT Southwestern Medical Center, shares some of the most exciting highlights from the 2017 American Heart Association Scientific Sessions, and how UT Southwestern is leading in the ground breaking research and medical contributions when it comes to your heart.